Approval · Notice of Compliance 34610 · 2024
TRULANCE: Notice of Compliance 34610
Issued December 24, 2024
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 34610
- Date
- December 24, 2024
- Company
- Bausch Health, Canada Inc.Laval, Quebec, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- Addition of new indication: for the treatment of chronic idiopathic constipation in adults
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| TRULANCE | Not yet assigned | — |
Medicinal ingredients
- PLECANATIDE 3 MG per TAB